Publication: 3149

Publication: 3149

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood vol 135 (25) 2224-2234

Year:: 2020
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 9

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U10CA180791, U10CA180833, U10CA180850, UG1CA189960

Corr. Author:
Authors:: Heiko Schöder Mei-Yin C. Polley Michael V. Knopp Nathan Hall Lale Kostakoglu Jun Zhang Howard R. Higley Gary Kelloff Heshan Liu Andrew D. Zelenetz Bruce D. Cheson Nina Wagner-Johnston Brad S. Kahl Jonathan W. Friedberg Eric D. Hsi John P. Leonard Lawrence H. Schwartz Wyndham H. Wilson Nancy L. Bartlett

Networks:: CAPITAL, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, NY018, PA121, VA009

Study: CALGB-50303
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-580603
Phases:: 3, 3

Keywords:: 8, 39, Clinical Trials and Observations